447.36MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of C4 Therapeutics Inc is 5.00, ranking 132 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 69.01%, representing a quarter-over-quarter decrease of 2.67%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.52% of shares outstanding, with 13.18% increase in holdings.
Institutional Shareholding
Shareholder Activity
RA Capital Management, LP
Lynx1 Capital Advisors LLC
Soleus Capital Management, L.P.
Bain Capital Life Sciences Investors, LLC
Two Sigma Investments, LP
BofA Global Research (US)